Exosomes of stem cells: a potential frontier in the treatment of osteoarthritis

Area of Science:

• Biomedical engineering
• Regenerative medicine
• Cell biology

Background:

• Osteoarthritis (OA) is a growing global health concern, significantly impacting patient quality of life and imposing economic burdens.
• Current OA treatments, including biotherapy, are insufficient to prevent or delay disease onset and progression.
• Exosomes, nanoscale bioactive substances mediating cell communication, are emerging as a promising therapeutic avenue for OA.

Purpose of the Study:

• To summarize the mechanisms and functions of stem cell-derived exosomes in delaying osteoarthritis.
• To explore the clinical significance and therapeutic potential of exosomes in OA treatment.
• To discuss the future prospects and challenges associated with exosome-based therapies for OA.

Main Methods:

• Literature review of recent studies on stem cell exosomes and osteoarthritis.
• Analysis of exosome biogenesis, cargo, and intercellular communication mechanisms.
• Evaluation of preclinical and clinical data regarding exosome efficacy in OA models.

Main Results:

• Stem cell exosomes facilitate intercellular communication, delivering bioactive molecules that can modulate OA pathogenesis.
• Evidence suggests exosomes can reduce inflammation, promote cartilage repair, and inhibit OA progression.
• Exosomes demonstrate significant potential for clinical application in OA management.

Conclusions:

• Stem cell-derived exosomes represent a novel and potent biotherapeutic strategy for osteoarthritis.
• Further research is needed to overcome challenges in exosome production, delivery, and clinical translation.
• Exosomes hold significant promise for delaying OA progression and improving patient outcomes.